VCIM
RCKT icon

Velan Capital Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Velan Capital Investment Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Sell
60,000
-234,643
-80% -$780K 0.13% 39
2026
Q1 		$1.05M Buy
+294,643
New +$1.17M 0.66% 24

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Velan Capital Investment Management's RCKT Position: Q2 2026 in Review

Velan Capital Investment Management reduced its Rocket Pharmaceuticals (RCKT) stake by 80% in Q2 2026, selling an estimated $780K and leaving 60,000 shares worth $205K. The position accounts for 0.13% of the portfolio, ranked #39.

Velan Capital Investment Management first reported a position in RCKT in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.05M in Q1 2026. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Velan Capital Investment Management held 60,000 shares of Rocket Pharmaceuticals worth $205K as of Q2 2026.
  • Velan Capital Investment Management sold 234,643 Rocket Pharmaceuticals shares in Q2 2026, an estimated $780K.
  • Rocket Pharmaceuticals made up 0.13% of Velan Capital Investment Management's portfolio in Q2 2026, its #39 holding.
  • Velan Capital Investment Management first reported a position in Rocket Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Velan Capital Investment Management's Rocket Pharmaceuticals position peaked at $1.05M in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Velan Capital Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.